CYP 0.00% 27.0¢ cynata therapeutics limited

The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory...

  1. 1,163 Posts.
    lightbulb Created with Sketch. 3868

    The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause (MEND)

    Now (yesterday) officially updated with VIC based hospitals also recruiting:

    https://hotcopper.com.au/data/attachments/3199/3199063-4c1553f66ff14ed73bad97c2c7e347dd.jpg

    https://clinicaltrials.gov/ct2/show/NCT04537351
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
0.000(0.00%)
Mkt cap ! $48.50M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 18895 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
27.0¢ 4998 1
View Market Depth
Last trade - 10.02am 08/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.